BMA Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$130.00
73.66% Upside
Mean Price Target
$114.09
52.41% Upside
Lowest Price Target
$79.00
5.53% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On May 05, 2026
Actual EPS vs Estimated EPS
BMA Earnings Per Share (EPS) History
According to financial reports, BMA (NYSE: BMA) reported an actual EPS of $1.98 for the quarter ending on Feb 25, 2026, compared to an estimated $1.38, resulting in a 43.48% surprise. In the prior quarter (Nov 26, 2025), BMA recorded an actual EPS of $-0.39 with a -158.21% surprise. See BMA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BMA has experienced notable EPS surprises, with the latest quarter ending Feb 25, 2026 showing a 43.48% beat. Previously, the quarter ending Nov 26, 2025 recorded a -158.21% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Feb 25, 2026 | 1.98 | 1.38 | +43.48% |
| Nov 26, 2025 | -0.39 | 0.67 | -158.21% |
| Aug 27, 2025 | 1.95 | 1.99 | -2.01% |
| May 28, 2025 | 0.65 | 1.66 | -60.84% |
| Apr 02, 2025 | 8.89 | 2.41 | +268.88% |
| Nov 27, 2024 | 5.17 | 2.19 | +136.07% |

